Average Co-Inventor Count = 5.34
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pfizer Corporation (25 from 4,455 patents)
2. Cystic Fibrosis Foundation Therapeutics, Inc. (3 from 5 patents)
3. Cystic Fibrosis Foundation (3 from 3 patents)
31 patents:
1. 11702424 - Bicyclic-fused heteroaryl or aryl compounds
2. 10793579 - Bicyclic-fused heteroaryl or aryl compounds
3. 10766904 - Bicyclic heteroaryl derivatives as CFTR potentiators
4. 10494374 - Pyrrolopyrimidines as CFTR potentiators
5. 10377762 - Bicyclic heteroaryl derivatives as CFTR potentiators
6. 10329302 - Bicyclic-fused heteroaryl or aryl compounds
7. 10316018 - Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
8. 10308615 - Heterocyclic compounds as inhibitors of Vanin-1 enzyme
9. 10301315 - Pyrrolopyrimidines as CFTR potentiators
10. 10208053 - Bicyclic heteroaryl derivatives as CFTR potentiators
11. 10174000 - Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
12. 10131670 - Bicyclic heteroaryl derivatives as CFTR potentiators
13. 9879022 - Bicyclic-fused heteroaryl or aryl compounds
14. 9458168 - Bicyclic-fused heteroaryl or aryl compounds
15. 8076356 - Triazolopyridinylsulfanyl derivatives as P38 map kinase inhibitors